A Clinical Trial to Evaluate the Safety and Efficacy in Subjects With Chronic Cough
Status:
Recruiting
Trial end date:
2023-12-01
Target enrollment:
Participant gender:
Summary
A Randomized, Double-Blind, Placebo-Controlled, Two-Period Crossover, Phase 2 Clinical Trial
to Evaluate the Safety, Tolerability, and Efficacy of ADX-629 Administered Orally to Subjects
with Chronic Cough